OSCOTECInc.
A clinical-stage drug discovery company developing innovative medicines for unmet needs.
039200 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 대왕판교로 700 A-901(삼평동,코리아바이오파크), 성남시
- Website:
- https://oscotec.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Oscotec Inc. is a clinical-stage drug discovery and development company. The company's mission, as stated on its platform, is to "create values by translating cutting edge science into innovative medicines for clinically unmet needs." Established in 1999, Oscotec focuses on identifying and advancing novel therapeutic candidates to address significant medical challenges, guided by the principle of "Translating science into medicine."
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-18 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.9 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-07-24 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.9 KB | ||
| 2025-07-18 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (진행성 고형암 치료 후보물질 OCT598 임상1상 한국 식품의약품안전처 …
|
Korean | 9.8 KB | ||
| 2025-06-20 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-06-02 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청등결정) (진행성 고형암 치료 후보물질 OCT-598 임상1상 임상시험계획(I…
|
Korean | 10.2 KB | ||
| 2025-05-30 00:00 |
Regulatory News Service
투자판단관련주요경영사항 (유한양행의 얀센바이오테크 기술이전 마일스톤 분배)
|
Korean | 8.5 KB | ||
| 2025-05-22 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-05-02 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (진행성 고형암 치료 후보물질 OCT-598 임상1상 임상시험계획(IND)…
|
Korean | 8.6 KB | ||
| 2025-04-23 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) (AXL 저해제 SKI-G-801 임상 1상 임상시험결과보고서(CSR) 수령)
|
Korean | 13.2 KB | ||
| 2025-04-18 00:00 |
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청) (면역성 혈소판감소증(ITP)의 1차 치료법 가능성에 대한 탐색적 2상 연…
|
Korean | 8.8 KB | ||
| 2025-04-18 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 102.6 KB | ||
| 2025-04-18 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-04-14 00:00 |
Board/Management Information
대표이사변경
|
Korean | 10.5 KB |
Automate Your Workflow. Get a real-time feed of all OSCOTECInc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for OSCOTECInc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
